As of December 2024, GeneReach Biotechnology has a market cap of $47.92M. This makes GeneReach Biotechnology the world's 24033th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $66.95M | -3.68% |
2023 | $69.50M | -40.23% |
2022 | $116.28M | -27.31% |
2021 | $159.97M | -27.82% |
2020 | $221.62M | 91.85% |
2019 | $115.52M | 74.87% |
2018 | $66.06M | 96.94% |
2017 | $33.54M | -2.00% |
2016 | $34.23M | -37.11% |
2015 | $54.42M | -41.33% |
2014 | $92.76M | 20.44% |
2013 | $77.01M | 0.00% |
2012 | $77.01M | - |